The Adenosine A1 Receptor Antagonist Slv320 Reduces Myocardial Fibrosis in Rats with 5/6 Nephrectomy Without Affecting Blood Pressure.
From: Department of Pharmacology and Toxicology, Center for Cardiovascular Research, Charité, Campus Mitte, Hessische Strasse 3-4, 10115 Berlin, Germany.
British journal of pharmacology
- Publish Date: Aug 2007
- ISSN: 0007-1188
- Volume: 151
- Issue: 7
- Pages: 1025-32
- Medium: Print
- Language: English
- Citation (JAMA): Kalk P, Eggert B, Relle K, et al. The Adenosine A1 Receptor Antagonist Slv320 Reduces Myocardial Fibrosis in Rats with 5/6 Nephrectomy Without Affecting Blood Pressure.. Br. J. Pharmacol. Aug 2007;151:1025-32
Abstract
BACKGROUND AND PURPOSE: Myocardial fibrosis is an unwanted effect associated with chronic renal failure. The adenosine system is involved in cardiac and renal function. Therefore, we investigated the novel selective adenosine A(1) receptor antagonist SLV320 focusing on its potential in preventing cardiomyopathy in rats with 5/6 nephrectomy. EXPERIMENTAL APPROACH: Male Sprague-Dawley rats were allocated to 4 groups of 12 rats each: 5/6 nephrectomy (5/6 NX), 5/6 NX plus SLV320 (10 mg kg(-1) d(-1) mixed with food), sham and sham plus SLV320. Study duration was 12 weeks, blood pressure was assessed repeatedly. At study end kidney function was assessed, blood samples and hearts were taken for histology/immunohistochemistry. Pharmacological properties of SLV320 were assessed using receptor binding and enzyme assays and in vivo. KEY RESULTS: SLV320 is a selective and potent adenosine A(1) antagonist in vitro (Ki=1 nM) with a selectivity factor of at least 200 versus other adenosine receptor subtypes. Functional A(1) antagonism was demonstrated in vivo. In rats with 5/6 NX SLV320 significantly decreased albuminuria by about 50%, but did not alter glomerular filtration rate (GFR). SLV320 normalized cardiac collagen I+III contents in 5/6 NX rats. SLV320 prevented nephrectomy-dependent rise in plasma levels of creatinine kinase (CK), ALT and AST. Blood pressure did not differ between study groups. CONCLUSION: SLV320 suppresses cardiac fibrosis and attenuates albuminuria without affecting blood pressure in rats with 5/6 nephrectomy, indicating that selective A(1) receptor antagonists may be beneficial in uraemic cardiomyopathy.
Mesh Headings (Keywords): Adenosine, Alanine Transaminase, Animals, Aspartate Aminotransferases, Blood Pressure, Cell Line, Collagen Type I, Collagen Type III, Creatine Kinase, Cyclohexanes, Endomyocardial Fibrosis, Fibronectins, Glomerular Filtration Rate, Heterocyclic Compounds, 2-Ring, Humans, Male, Molecular Structure, Myocardium, Nephrectomy, Radioligand Assay, Rats, Rats, Sprague-Dawley, Receptor, Adenosine A1, Rolipram, U937 Cells, Xanthines
Check for Full Text / PubMed Unique Identifier (PMID): 17558436
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.